Italian life sciences overseer reborn with nanotech and patenting in its remit
This article was originally published in Clinica
Executive Summary
Italy’s national committee for biosafety, biotechnology and life sciences (Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita, CNBBSV) meets for the first time today, following a “complete overhaul”.